Patents Assigned to ANOxA Corp.
  • Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine
    Patent number: 8217049
    Abstract: The use of type V phosphodiesterase inhibitors as a novel independent therapeutic modality in the treatment of exercise induced pulmonary hemorrhage in equine is described. The type V phosphodiesterase inhibitor is injected into the horse intravenously as a stand-alone agent from about one-half hour to about seven (7) days prior to the onset of strenuous exercise.
    Type: Grant
    Filed: May 1, 2007
    Date of Patent: July 10, 2012
    Assignee: ANOxA Corp.
    Inventor: Bryan J. Perry